EquityZen Growth Technology Fund LLC - Series 27
Raised
$1M
Investors
32
Min Invest
$0
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 27 is a Delaware pooled investment fund filed by Inc Equity Zen on 2016-02-11, raising $1.3M from 32 investors under Rule 506(b) and Section 3(c)(1). This is part of EquityZen's platform of pre-IPO access vehicles, with over 1,800 related EDGAR entities filing similar series-based SPVs.
This pre-IPO access vehicle uses the standard 506(b)/3(c)(1) exemption pattern typical of EquityZen's deal-by-deal series structure. The $1.3M raise across 32 investors reflects an average commitment of approximately $41K per investor, consistent with retail-accessible pre-IPO investment opportunities on structured platforms.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Equity Zen Inc
Executive Officer, Director · New York, NY
Shriram Bhashyam
Executive Officer, Director · New York, NY
Jens Beyrich
Executive Officer · Salt Lake City, UT
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.